BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 36479126)

  • 1. Integrated analysis of multiple microarray studies to establish differential diagnostic models of Crohn's disease and ulcerative colitis based on a metalloproteinase-associated module.
    Deng J; Zhao N; Lv LP; Ma P; Zhang YY; Xu JB; Zhou XP; Chen ZA; Zhang YY
    Front Immunol; 2022; 13():1022850. PubMed ID: 36479126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated multiple microarray studies by robust rank aggregation to identify immune-associated biomarkers in Crohn's disease based on three machine learning methods.
    Chen ZA; Ma HH; Wang Y; Tian H; Mi JW; Yao DM; Yang CJ
    Sci Rep; 2023 Feb; 13(1):2694. PubMed ID: 36792688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn's disease from ulcerative colitis.
    James JP; Nielsen BS; Christensen IJ; Langholz E; Malham M; Poulsen TS; Holmstrøm K; Riis LB; Høgdall E
    Sci Rep; 2023 Oct; 13(1):18421. PubMed ID: 37891214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of hub inflammatory bowel disease biomarkers and identification of immune-related functions based on basement membrane genes.
    Lin P; Hua J; Teng Z; Lin C; Liu S; He R; Chen H; Yao H; Ye J; Zhu G
    Eur J Med Res; 2023 Jul; 28(1):247. PubMed ID: 37481583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
    Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
    World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying candidate genes for discrimination of ulcerative colitis and Crohn's disease.
    Lin LJ; Zhang Y; Lin Y; Jin Y; Zheng CQ
    Mol Biol Rep; 2014 Oct; 41(10):6349-55. PubMed ID: 25182475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling.
    Sipos F; Galamb O; Wichmann B; Krenács T; Tóth K; Leiszter K; Muzes G; Zágoni T; Tulassay Z; Molnár B
    Dis Markers; 2011; 30(1):1-17. PubMed ID: 21508504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
    Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
    Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
    Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
    Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
    Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
    Plevy S; Silverberg MS; Lockton S; Stockfisch T; Croner L; Stachelski J; Brown M; Triggs C; Chuang E; Princen F; Singh S
    Inflamm Bowel Dis; 2013 May; 19(6):1139-48. PubMed ID: 23518807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
    Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
    World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
    Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
    Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease.
    Bjerrum JT; Nyberg C; Olsen J; Nielsen OH
    J Intern Med; 2014 May; 275(5):484-93. PubMed ID: 24206446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease.
    Arafah K; Kriegsmann M; Renner M; Lasitschka F; Fresnais M; Kriegsmann K; von Winterfeld M; Goeppert B; Kriegsmann J; Casadonte R; Kazdal D; Bulet P; Longuespée R
    Proteomics Clin Appl; 2020 Jul; 14(4):e1900110. PubMed ID: 32003543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.